Real-World Outcomes of First-Line Treatment of Metastatic or Locally Advanced Upper Tract Urothelial Carcinoma With Enfortumab Vedotin Plus Pembrolizumab : A French Multicenter Retrospective Observational Study
Clinical trial NCT07633353 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07633353
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.